Top

Published in:

Open Access 01-12-2018 | Commentary

Transgender Corneal Donors: A Dilemma Worthy of Attention

Authors: Majid Moshirfar, Tanner W. Brown, Jackson L. Goldberg, William D. Wagner, Yasmyne C. Ronquillo

Published in: Ophthalmology and Therapy | Issue 2/2018

Abstract

Currently, there are no specific guidelines in place to direct eye banks on how to deal with donated tissue from transgender individuals. This commentary will examine the history of corneal transplantation and the importance of the corneal tissue donor. In doing so, the donor selection criteria established by the Food and Drug Administration will be presented. Additionally, the history of blood donor deferral policies created for men who have sex with men and how those policies have changed over time will be explored. We provide an evidence-based framework for potential guidelines regarding the transgender population and eye tissue donation.

Crawford AZ, Patel DV, McGhee CN. A brief history of corneal transplantation: from ancient to modern. Oman J Ophthalmol. 2013;6(Suppl 1):S12–7.PubMedPubMedCentral

Tan DT, Dart JK, Holland EJ, Kinoshita S. Corneal transplantation. Lancet. 2012;379(9827):1749–61.CrossRef

Nguyen NX, Seitz B, Martus P, Langenbucher A, Cursiefen C. Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. Am J Ophthalmol. 2007;144(2):318–9.CrossRef

Jullienne R, He Z, Aldossary M, et al. Global survey of corneal transplantation and eye banking. JAMA Ophthalmol. 2016;134(2):167–73.CrossRef

EBAA. Medical standards. Int J Eye Bank. 2016;4(3):1–35.

FDA. Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 2007. https://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/tissue/ucm091345.pdf. Accessed 13 July 2018.

Frieden TR, Harold Jaffe DW, Thacker SB, et al. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services Morbidity and Mortality Weekly Report Recommendations and Reports Centers for Disease Control and Prevention MMWR Editorial and Production Staff MMWR Editorial Board. http://www.cdc.gov/mmwr/cme/conted.html. Accessed 19 July 2018.

Centers for Disease Control and Prevention (CDC). Diagnoses of HIV infection in the united states and dependent areas, 2016. HIV Surveill Rep. 2016;28(28).

FDA. Revised recommendations for reducing the risk of human immunodeficiency virus transmission by blood and blood products: guidance for industry. 2015. pp. 1–27. http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm. Accessed 8 July 2018.

10.

GLAAD. GLAAD media reference guide, 10th edition. 2016. http://www.glaad.org/sites/default/files/GLAAD-Media-Reference-Guide-Tenth-Edition.pdf. Accessed 9 July 2018.

11.

Sacks CA, Goldstein RH, Walensky RP. Rethinking the ban—the U.S. blood supply and men who have sex with men. N Engl J Med. 2017;376(2):174–7.CrossRef

12.

Vargo J, Smith K, Knott C, et al. Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA. Transfusion. 2002;42(7):876–85. https://doi.org/10.1046/j.1537-2995.2002.00130.x.CrossRefPubMed

13.

Kucirka LM, Sarathy H, Wolf JH, et al. Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant. 2011;11(6):1176–87.CrossRef

14.

Humar A, Morris M, Blumberg E, et al. Nucleic acid testing (NAT) of organ donors: is the ‘best’ test the right test? A consensus conference report. Am J Transplant. 2010;10(4):889–99. https://doi.org/10.1111/j.1600-6143.2009.02992.x.CrossRefPubMed

15.

Brailsford SR, Kelly D, Kohli H, Slowther A, Watkins NA. Who should donate blood? Policy decisions on donor deferral criteria should protect recipients and be fair to donors. Transfus Med. 2015;25(4):234–8. https://doi.org/10.1111/tme.12225.CrossRefPubMed

16.

Clark H, Babu AS, Wiewel EW, Opoku J, Crepaz N. Diagnosed HIV infection in transgender adults and adolescents: results from the national HIV surveillance system, 2009–2014. AIDS Behav. 2017;21(9):2774–83.CrossRef

17.

Stephens SC, Bernstein KT, Philip SS. Male to female and female to male transgender persons have different sexual risk behaviors yet similar rates of STDs and HIV. AIDS Behav. 2011;15(3):683–6. https://doi.org/10.1007/s10461-010-9773-1.CrossRefPubMed

18.

Luzzati R, Zatta M, Pavan N, et al. Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among transgender persons referred to an Italian center for total sex reassignment surgery. Sex Transm Dis. 2016;43(7):407–11.CrossRef

19.

Unger CA. Hormone therapy for transgender patients. Transl Androl Urol. 2016;5(6):877–84.CrossRef

20.

Leinung M, Urizar M, Patel N, Sood S. Endocrine treatment of transsexual persons: extensive personal experience. Endocr Pract. 2013;19(4):644–50. https://doi.org/10.4158/EP12170.OR.CrossRefPubMed

21.

Flores AR, Herman JL, Gates GJ, Brown TNT. How many adults identify as transgender in the United States? The Williams Institue. 2016. pp 1–13. http://williamsinstitute.law.ucla.edu/wp-content/uploads/How-Many-Adults-Identify-as-Transgender-in-the-United-States.pdf. Accessed 8 July 2018.

22.

The Lewin Group I. Cost-benefit analysis of corneal transplant. 2013. http://restoresight.org/wp-content/uploads/2014/03/Lewin-Study-Sept-2013.pdf. Accessed 9 July 2018.

Title: Transgender Corneal Donors: A Dilemma Worthy of Attention
Authors: Majid Moshirfar
Tanner W. Brown
Jackson L. Goldberg
William D. Wagner
Yasmyne C. Ronquillo
Publication date: 01-12-2018
Publisher: Springer Healthcare
Published in: Ophthalmology and Therapy / Issue 2/2018
Print ISSN: 2193-8245
Electronic ISSN: 2193-6528
DOI: https://doi.org/10.1007/s40123-018-0148-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Transgender Corneal Donors: A Dilemma Worthy of Attention

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2018

Latest Clinical Approaches in the Ocular Management of Cystinosis: A Review of Current Practice and Opinion from the Ophthalmology Cystinosis Forum

Continuous Transitional Focus (CTF): A New Concept in Ophthalmic Surgery

Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence

Potential Effect of Cyclophosphamide on Bleb Survival in Five Patients with Multiple Sclerosis Who Underwent Glaucoma Surgery

Antibiotic Resistance Rates by Geographic Region Among Ocular Pathogens Collected During the ARMOR Surveillance Study

Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page